All Posts Tagged With: "PFE"
(NVS) Novartis Presents Afinitor Data
Recently, Novartis (NVS) presented data from a late-stage study (EXIST-1) of its cancer drug Afinitor (everolimus). The randomized, placebo-controlled, double-blind, multicenter study evaluated the safety...
(ADP) Stock Market News for July 8, 2011 – Market News
On Thursday, positive jobs and retail reports lifted investor sentiment and subsequently boosted the benchmarks which edged closer to 2011 highs. Nonetheless, volumes remained tight as investors anxiously await crucial non-farm payroll data from the government.
The...
(NVS) Novartis AG’s Afinitor Impresses Again
It seems Novartis AG’s (NVS) breast cancer drug, Afinitor (everolimus), is getting into a habit of delivering positive news. Right after the Committee for Medicinal Products for Human Use (CHMP) of the European...
(OPTR) Optimer Pharmaceuticals Analyst Maintains Neutral
We have maintained a Neutral rating on Optimer Pharmaceuticals, Inc. (OPTR) with a target price of $12.00 per share.
We find the US Food and Drug Administration’s (FDA) approval of Optimer’s first...
(ENDP) Endo Pharmaceuticals’ Back Pain Drug Disappoints
Endo Pharmaceuticals (ENDP) recently suffered a pipeline setback with its candidate axomadol performing disappointingly in a mid-stage trial (n=236). Top line results from the study revealed that Endo Pharma’s...
(BAC) Stock Market News for July 1, 2011 – Market News
The Street ended one of its most volatile quarters, with positive economic reports and a temporary solution to the Greece debt crisis lifting the benchmarks to post their biggest four-day rally since September. The technology sector and energy sector lifted the mood further...
(PFE) Pfizer Drug Accepted for Standard FDA Review
Pfizer Inc. (PFE) recently announced that its regulatory application for oncology candidate, axitinib has been accepted for standard review by the US Food and Drug Administration (FDA). The company is seeking...
(NVS) Novartis AG Afinitor Backed in EU
Novartis AG (NVS) received a boost recently when the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended approval of its drug Afinitor for the treatment...
(WPI) Watson Pharmaceuticals Files More Abbreviated New Drug Applications
Watson Pharmaceuticals Inc. (WPI) recently announced that it has filed Abbreviated New Drug Applications (ANDA) with the US Food and Drug Administration (FDA) to market its generic version of GlaxoSmithKline...
(BMRN) BioMarin Pharmaceutical to Buy Pfizer Plant
BioMarin Pharmaceutical Inc. (BMRN) recently announced that it will acquire an integrated biologics manufacturing plant from pharma giant Pfizer Inc....
(AGNC) Company News for June 28, 2011 – Corporate Summary
• Shares of online company Amazon.com, Inc. (NASDAQ:AMZN) gained 4.52% after analysts at Morgan Stanley (NYSE:MS) opined that the company’s fourth quarter profits...
(PFE) Pfizer and Pain Therapeutics Get Bad News for Remoxy
The US Food and Drug Administration recently dealt a blow to Pfizer (PFE) and Pain Therapeutics, Inc. (PTIE) by issuing a second complete...
(ENDP) Endo Pharmaceuticals Announces FDA Action Date
Endo Pharmaceuticals (ENDP) recently announced that the US Food and Drug Administration (FDA) has issued a new action date for the new formulation of painkiller Opana ER. The FDA stated that it will review...
(RDY) Dr. Reddy’s Laboratories Launches Generic Levaquin
Dr. Reddy’s Laboratories (RDY) recently announced the launch of its generic version of Johnson & Johnson’s (JNJ) antibiotic drug,...
(PFE) Pfizer’s Lyrica Holds Promise
Pfizer Inc. (PFE) recently presented positive top-line data on its blockbuster drug, Lyrica. Pfizer said that Lyrica met the primary endpoint in a study that was being conducted in patients with chronic central...
(ABT) Abbott Labs Boosts Immunology Pipeline
Abbott Labs (ABT) recently entered into a global agreement with Biotest AG for the development and commercialization of a novel anti-CD4 antibody, BT-061.
The Candidate: BT-061
The...
(XLE) Stock Market News for June 24, 2011 – Market News
On Thursday, markets rebounded from session lows as Greece agreed to implement a five-year austerity plan. Markets were dragged lower early in the day after a drop in oil prices. However, news from the domestic front was discouraging with disappointing economic reports on...
(BMY) Bristol-Myers Squibb and Pfizer Report Positive Data on Blood Thinner Apixaban Drug
Recently, Bristol-Myers Squibb Company (BMY) and partner Pfizer (PFE) announced encouraging top line data from a late-stage study (ARISTOTLE:...
(PFE) Pfizer and Acura Pharmaceuticals Win FDA Approval for Oxecta
Pfizer Inc. (PFE) and partner Acura Pharmaceuticals Inc. (ACUR) recently received US Food and Drug Administration (FDA) approval for their...
(VVUS) Vivus’ Erectile Dysfunction Drug on Track
Vivus Inc. (VVUS) recently reported positive results from a late-stage trial, REVIVE-RP (TA-303), on avanafil. The study evaluated the safety and efficacy of avanafil in the treatment of erectile dysfunction...
(ENDP) Endo Pharmaceuticals Holdings Buys American Medical
Recently, Endo Pharmaceuticals Holdings Inc. (ENDP) completed the purchase of American Medical Systems, a leading pelvic-health device provider, in an all cash deal worth approximately $2.9 billion.
By...
(PFE) Pfizer’s Chantix Could Increase Heart Risk
The US Food and Drug Administration (FDA) recently announced that Pfizer’s (PFE) smoking cessation aid Chantix (varenicline) could be linked with a small, increased risk of certain cardiovascular adverse...
(WPI) Watson Pharmaceuticals Wins Favorable Ruling Against Teva Pharmaceutical Industries
Watson Pharmaceuticals Inc. (WPI) recently announced that the United States District Court for the District of Nevada denied Teva Pharmaceutical Industries Ltd.’s (
21Jun2011 | vitalstocks | 0 comments | Continued(AFAM) Company News for June 21, 2011 – Corporate Summary
• Manufacturer and distributors of stainless steel and titanium products, Carpenter Technology (NYSE:CRS) has concluded a merger agreement with Latrobe Specialty Metals as per which the former will acquire the latter...
(APD) Air Products & Chemicals Acquires Poly-Flow Engineering
The industrial gas company Air Products & Chemicals Inc. (APD) announced that it has acquired Poly-Flow Engineering (PFE), an Albuquerque, N.M., company that makes equipment for the semiconductor industry...
(BMY) Bristol-Myers Squibb Company Gets Another Feather in its Cap
Bristol-Myers Squibb Company’s (BMY) product portfolio was boosted further when the US Food and Drug Administration (FDA) approved its drug Nulojix (belatacept) to prevent the rejection of transplanted kidneys...
(WPI) Watson Pharmaceuticals Seeks Generic Viagra Approval
Watson Pharmaceuticals Inc. (WPI) recently announced that it has filed an Abbreviated New Drug Application (ANDA) with the US Food and Drug Administration (FDA) to market its generic version of Pfizer...
(RDY) Dr. Reddy’s Laboratories Announces FDA Warning Letter
Dr. Reddy’s Laboratories (RDY) recently announced that the US Food and Drug Administration (FDA) issued a four item warning letter regarding the company’s chemical manufacturing facility at Cuernavaca,...
(INCY) Incyte Corporation Analyst Maintains Neutral on Shares
We are maintaining our Neutral recommendation on Incyte Corporation (INCY) with a target price of $18.00.
Incyte is a Wilmington, Delaware-based drug discovery and development company with a focus...
(BMY) Bristol-Myers Squibb Compan Gets Good News
Bristol-Myers Squibb Company (BMY) received a boost when its blood-thinner Eliquis (apixaban) was cleared by the European Commission (EC) in 27 nations of the European Union (EU) for preventing venous thromboembolic...